Ovid Therapeutics Inc (OVID)

Apr 15, 2026

OVID.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Apr 15, 2026

Apr 15, 2026

OVID Reiterated by Wedbush -- Price Target Maintained at $7.00 - GuruFocus

Apr 15, 2026

Apr 15, 2026

Leerink reiterates Ovid Therapeutics stock rating on KCC2 potential By Investing.com - Investing.com South Africa

Apr 15, 2026

Apr 15, 2026

Ovid Therapeutics' (OVID) "Outperform" Rating Reiterated at Wedbush - MarketBeat

Apr 15, 2026

Apr 15, 2026

Ovid Therapeutics Inc. (OVID) Discusses KCC2 Deep Dive and Pipeline Advances in CNS DisordersSlideshow - Seeking Alpha

Apr 15, 2026

Apr 13, 2026

Value Recap: What hedge funds are buying Ovid Therapeutics Inc2026 Analyst Calls & AI Powered Buy and Sell Recommendations - baoquankhu1.vn

Apr 13, 2026

Apr 13, 2026

VIX Spike: Does Ovid Therapeutics Inc have declining or rising EPS2026 Analyst Calls & Risk Controlled Swing Alerts - baoquankhu1.vn

Apr 13, 2026

Apr 10, 2026

Whale Trades: What are Ovid Therapeutics Incs growth levers2026 Gainers & Low Volatility Stock Recommendations - baoquankhu1.vn

Apr 10, 2026

Apr 10, 2026

OVID Should I Buy - Intellectia AI

Apr 10, 2026

Apr 10, 2026

H.C. Wainwright raises Ovid Therapeutics stock price target to $4 By Investing.com - Investing.com Australia

Apr 10, 2026

Apr 09, 2026

[Form 4] Ovid Therapeutics Inc. Insider Trading Activity - Stock Titan

Apr 09, 2026

Apr 09, 2026

Ovid Therapeutics (NASDAQ: OVID) director granted RSUs in lieu of cash pay - Stock Titan

Apr 09, 2026

Apr 09, 2026

Director Kevin Fitzgerald awarded Ovid Therapeutics (OVID) RSU compensation - Stock Titan

Apr 09, 2026

Apr 09, 2026

Trade Recap: Why is Ovid Therapeutics Inc stock going up2026 Top Gainers & Real-Time Chart Pattern Alerts - baoquankhu1.vn

Apr 09, 2026

Apr 09, 2026

Ovid Therapeutics Surge: Positive Phase 1 Data Ignites Market Confidence - timothysykes.com

Apr 09, 2026

Apr 09, 2026

Ovid Therapeutics (OVID): HC Wainwright & Co. Raises Price Targe - GuruFocus

Apr 09, 2026

Apr 09, 2026

H.C. Wainwright raises Ovid Therapeutics stock price target to $4 - Investing.com

Apr 09, 2026

Apr 09, 2026

Big Money Moves: Why is Ovid Therapeutics Inc stock going up - baoquankhu1.vn

Apr 09, 2026

Apr 09, 2026

Ovid Therapeutics Inc. (OVID) stock price, news, quote and history - Yahoo Finance UK

Apr 09, 2026

Apr 08, 2026

Ovid Therapeutics to Host Potassium-Chloride Co-transporter 2 (KCC2) Deep Dive R&D Event on Tuesday, April 14 - The Manila Times

Apr 08, 2026

Apr 07, 2026

Ovid Therapeutics Shares Surge After Positive Phase 1 Results and Financing News - StocksToTrade

Apr 07, 2026

Apr 06, 2026

Earnings Report: Is Ovid Therapeutics Inc being accumulated by smart money2026 Breakouts & Breakdowns & Fast Gain Stock Tips - baoquankhu1.vn

Apr 06, 2026

Apr 05, 2026

Ovid Therapeutics Inc (OVID) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus

Apr 05, 2026

Apr 02, 2026

OVID.O Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 02, 2026

Apr 01, 2026

OVID News & Events - intellectia.ai

Apr 01, 2026

Apr 01, 2026

IPO Launch: Does Ovid Therapeutics Inc have declining or rising EPSWeekly Trend Recap & Daily Growth Stock Investment Tips - baoquankhu1.vn

Apr 01, 2026

Mar 31, 2026

Gains Report: Can Ovid Therapeutics Inc maintain its current growth rate2026 Opening Moves & Free Technical Confirmation Trade Alerts - baoquankhu1.vn

Mar 31, 2026

Mar 31, 2026

Ovid Therapeutics (OVID) price target increased by 14.29% to 4.87 - MSN

Mar 31, 2026

Mar 31, 2026

Rate Hike: Is Ovid Therapeutics Inc still a buy after recent gains2026 Chart Watch & High Accuracy Trade Alerts - baoquankhu1.vn

Mar 31, 2026

Mar 30, 2026

OVID Therapeutics Inc (NASDAQ:OVID) Passes Minervini's High-Growth Momentum and Trend Template Filters - ChartMill

Mar 30, 2026

Mar 29, 2026

Aug Reactions: How does Ovid Therapeutics Inc score in quality rankingsCEO Change & Weekly Stock Performance Updates - baoquankhu1.vn

Mar 29, 2026

Mar 29, 2026

Aug Big Picture: Does Ovid Therapeutics Inc have declining or rising EPSBuy Signal & Weekly Momentum Stock Picks - baoquankhu1.vn

Mar 29, 2026

Mar 27, 2026

Ovid Therapeutics' (OVID) Buy Rating Reaffirmed at BTIG Research - MarketBeat

Mar 27, 2026

Mar 27, 2026

Ovid spikes as Wedbush moves to Outperform on lead asset - MSN

Mar 27, 2026

Mar 26, 2026

Lifesci Capital Has Negative Estimate for OVID Q1 Earnings - MarketBeat

Mar 26, 2026

Mar 26, 2026

Ovid Therapeutics (NASDAQ:OVID) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat

Mar 26, 2026

Mar 25, 2026

Ovid Therapeutics (NASDAQ: OVID) chair exercises 47,333-share warrant at $1.40 - Stock Titan

Mar 25, 2026

Mar 25, 2026

Investors pour $60M into Ovid Therapeutics to advance seizure drugs - Crain's New York Business

Mar 25, 2026

Mar 24, 2026

Ovid Therapeutics' new epilepsy trial data ignites rally - MSN

Mar 24, 2026

Mar 23, 2026

Ovid Therapeutics secures $60M funding to advance epilepsy drug programs - MSN

Mar 23, 2026

Mar 22, 2026

If You Invested $1,000 in Ovid Therapeutics Inc (OVID) - Stock Titan

Mar 22, 2026

Mar 21, 2026

Here's why Ovid Therapeutics stock popped higher today - MSN

Mar 21, 2026

Mar 21, 2026

Wall Street Zen Upgrades Ovid Therapeutics (NASDAQ:OVID) to Hold - MarketBeat

Mar 21, 2026

Mar 20, 2026

Ovid Therapeutics Sells Ganaxolone Royalty Rights for $7M to Immedica Pharma - MSN

Mar 20, 2026

Mar 20, 2026

Ovid Therapeutics Stock Surges on Positive Drug Trial Data and Financing Plans - StocksToTrade

Mar 20, 2026

Mar 20, 2026

Ovid Shares Surge with Positive Phase 1 Results and Strategic Moves - timothysykes.com

Mar 20, 2026

Mar 20, 2026

Wedbush Forecasts Strong Price Appreciation for Ovid Therapeutics (NASDAQ:OVID) Stock - MarketBeat

Mar 20, 2026

Mar 20, 2026

Ovid Therapeutics (OVID) Sees Price Target Raised by Wedbush | O - gurufocus.com

Mar 20, 2026

Mar 20, 2026

Bond Watch: How does Ovid Therapeutics Inc score in quality rankingsMarket Performance Report & Daily Technical Forecast Reports - baoquankhu1.vn

Mar 20, 2026

Mar 20, 2026

Ovid Therapeutics: Seizing The Moment With Phase 2 Ready Assets And PIPE Funding - Seeking Alpha

Mar 20, 2026